Tara Belsare
Psychiatry · Endwell, NYNPI 1245355155
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 32.1% of the total. Reporting peaked in 2022 at $1,242 and has fallen 96.9% since, to $38 in 2025.
Across 172 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$401
- Sunovion Pharmaceuticals Inc.$388
- Otsuka America Pharmaceutical, Inc.$209
- Johnson & Johnson$202
- E.r. Squibb & Sons, L.L.C.$168
- plus $908 from 13 others
What the payments were for
- Food & beverage$3,30799%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $1,078 |
| Alkermes, Inc. | 18 | $401 |
| Sunovion Pharmaceuticals Inc. | 20 | $388 |
| Otsuka America Pharmaceutical, Inc. | 11 | $209 |
| Johnson & Johnson | 11 | $202 |
| E.r. Squibb & Sons, L.L.C. | 3 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $166 |
| Lundbeck LLC | 11 | $162 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $99 |
| Indivior Inc. | 5 | $92 |
| Neurocrine Biosciences, Inc. | 5 | $89 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Corium, LLC | 2 | $43 |
| OWP Pharmaceuticals, Inc. | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Novo Nordisk | 2 | $29 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Bioxcel Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,354 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 35 | $10,349 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 39 | $8,231 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Endwell
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.